HOXA9 Antikörper (AA 1-272)
Kurzübersicht für HOXA9 Antikörper (AA 1-272) (ABIN561318)
Target
Alle HOXA9 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 1-272
-
Verwendungszweck
- Mouse monoclonal antibody raised against a full length recombinant HOXA9.
-
Sequenz
- MATTGALGNY YVDSFLLGAD AADELSVGRY APGTLGQPPR QAATLAEHPD FSPCSFQSKA TVFGASWNPV HAAGANAVPA AVYHHHHHHP YVHPQAPVAA AAPDGRYMRS WLEPTPGALS FAGLPSSRPY GIKPEPLSAR RGDCPTLDTH TLSLTDYACG SPPVDREKQP SEGAFSENNA ENESGGDKPP IDPNNPAANW LHARSTRKKR CPYTKHQTLE LEKEFLFNMY LTRDRRYEVA RLLNLTERQV KIWFQNRRMK MKKINKDRAK DE
-
Kreuzreaktivität
- Human
-
Produktmerkmale
- Antibody Reactive Against Recombinant Protein.
-
Immunogen
- HOXA9 (AAH06537, 1 a.a. ~ 272 a.a) full-length recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
-
Isotyp
- IgG1
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Buffer
- In 1x PBS, pH 7.4
-
Handhabung
- Aliquot to avoid repeated freezing and thawing.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
-
-
: "Delayed biosynthesis of varicella-zoster virus glycoprotein C: upregulation by hexamethylene bisacetamide and retinoic acid treatment of infected cells." in: Journal of virology, Vol. 80, Issue 19, pp. 9544-56, (2006) (PubMed).
-
: "Delayed biosynthesis of varicella-zoster virus glycoprotein C: upregulation by hexamethylene bisacetamide and retinoic acid treatment of infected cells." in: Journal of virology, Vol. 80, Issue 19, pp. 9544-56, (2006) (PubMed).
-
- HOXA9 (Homeobox A9 (HOXA9))
-
Andere Bezeichnung
- HOXA9
-
Hintergrund
-
Full Gene Name: homeobox A9
Synonyms: ABD-B,HOX1,HOX1.7,HOX1G,MGC1934 -
Gen-ID
- 3205
Target
-